Daily non-political popular news in brief.

A tricky tumor virus

Viruses use many tricks to gain control over their host cells and to reprogram them to their own advantage. Dr. Arnd Kieser and his colleagues of the Department of Gene Vectors of the Helmholtz Zentrum Munich, Germany, were able to show in a recent publication in PLoS Biology by which mechanism Epstein-Barr virus exploits a signal protein of its host cell, which normally mediates programmed cell death, in order to convert the cell into a cancer cell.

Read more »

Keywords: tricky, tumor, virus, viru

« Previous | Next »

Similar news on "A tricky tumor virus":

1. Blood-vessel blocker aids cancer-killing virus
   11-27-2007 · EurekAlert!
   Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
   Similar news · Read more »
   
2. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
   02-15-2008 · EurekAlert!
   Researchers in a multi-institutional study led by Cincinnati Children's Hospital Medical Center slowed the growth of two particularly stubborn solid tumor cancers -- neuroblastoma and peripheral nerve sheath tumors -- without harming healthy tissues by inserting instructions to inhibit tissue growth into an engineered virus, according to study results published in the Feb. 15 Cancer Research.
   Similar news · Read more »
   
3. An AIDS-related virus tricks cells to become tumors, new Penn study finds
   11-08-2006 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth. The finding, published in the most recent issue of PLoS Pathogens, offers new potential strategies for treating Kaposi's sarcoma and other cancers associated with viruses
   Similar news · Read more »
   
4. Mouse mammary tumor virus can replicate in human cells
   10-10-2007 · EurekAlert!
   Mouse mammary tumor virus -- which causes mammary cancer in mice -- can replicate and spread in human cells, research published this week shows. The study, published in the online open access journal Retrovirology, adds weight to the theory that MMTV might be involved in causing human breast cancer.
   Similar news · Read more »
   
5. Customized virus kills brain tumor stem cells that drive lethal cancer
   09-11-2007 · EurekAlert!
   A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
6. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
   10-30-2006 · EurekAlert!
   Mayo Clinic Cancer Center has opened a new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme, a largely untreatable brain tumor.
   Similar news · Read more »
   
7. Penn study suggests new model for testing and discovery of anti-HIV drugs
   02-08-2007 · EurekAlert!
   Researchers at the University of Pennsylvania School of Medicine are the first to show that a mouse protein, whose human equivalent is related to defense against HIV-1, inhibits the infection and spread of a mouse tumor virus. The study provides a new model for the discovery and evaluation of anti-HIV drugs.
   Similar news · Read more »
   
8. 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus
   11-02-2007 · EurekAlert!
   A group at Hiroshima University Hospital performed a matched historical controlled study on whether a 24-week course of interferon-alpha therapy, after curative treatment for primary hepatocellular carcinoma associated with hepatitis C virus, could influence tumor recurrence, patient survival, and liver function. Patients with sustained virological responses had reduced recurrence, prolonged survival and a preserved liver function. The group also determined that viral eradication was the most important factor in such patients.
   Similar news · Read more »
   
9. Finnish scientists discovered a new approach to treat virus-induced lymphomas
   03-15-2007 · EurekAlert!
   Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi’s sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki have discovered that activation of the p53 pathway offers a novel effective treatment modality for KSHV-infected lymphomas.
   Similar news · Read more »
   
10. JCI table of contents: Oct. 1, 2007
    10-01-2007 · EurekAlert!
    This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published Oct. 1, 2007, in the JCI, including: "Humans MIFfed by West Nile Virus"; "Driving force behind common cause of blindness illuminated"; "It's in your genes: genetic link to susceptibility to infectious mononucleosis"; "Unravelling why obese individuals become diabetic"; "FGF2 and PDGF-BB work together to promote tumor growth"; and others.
    Similar news · Read more »